Passage BIO PASG Institutional Ownership

Ownership Summary

Passage BIO, Inc. (NASDAQ:PASG) is held by 35 institutional investors per 13F filings through March 2026.

• Their combined ownership stood at 55.5% of outstanding shares in March 2026, up from 49.7% in December 2025.
• They increased total shares held in PASG by 28.43% quarter over quarter, and investors in Passage BIO decreased 20.45% from a year ago.
• Of these 35 funds, 17 grew their exposure to Passage BIO, 5 cut back, and 13 maintained positions.
• In total, institutional investors held 1.78Mn shares in Passage BIO as of March 2026, up by 394.06K shares quarter on quarter, and down 40.53K shares year over year.
• Lynx1 Capital Management LP leads ownership in PASG with 623.7K shares as of March 31, 2026, equal to 19.46% of outstanding shares.
• The biggest buyers of Passage BIO for the quarter ending March 2026 included VANGUARD CAPITAL MANAGEMENT LLC (113.96K), Ikarian Capital, LLC (68.12K), Yiheng Capital Management, L.P. (51.8K), UBS Group AG (26.06K), RENAISSANCE TECHNOLOGIES LLC (24.52K).
• The biggest sellers of Passage BIO for the quarter ending March 2026 included Morgan Stanley (1.62K), BlackRock, Inc. (308), Rockefeller Capital Management L.P. (200), SBI Securities Co., Ltd. (18), OSAIC HOLDINGS, INC. (5).
• Per Business Quant, the top 10 investors in PASG for the quarter ending March 2026 include Lynx1 Capital Management LP (623.7K), Vestal Point Capital, LP (305.0K), RENAISSANCE TECHNOLOGIES LLC (133.61K), Eversept Partners, LP (131.58K), VANGUARD CAPITAL MANAGEMENT LLC (113.96K), Yiheng Capital Management, L.P. (86.1K), Erste Asset Management GmbH (85.26K), Ikarian Capital, LLC (68.12K), GEODE CAPITAL MANAGEMENT, LLC (41.38K), BlackRock, Inc. (28.6K).